Standard Biotools Inc. SEC filings LAB
Standard Biotools Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jun 30, 2016. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 425 | Filing | Nov 3, 2026 | — |
| EFFECT | Filing | Oct 21, 2026 | — |
| 425 | Filing | Oct 5, 2026 | — |
| 425 | Filing | Sep 30, 2026 | — |
| 425 | Filing | Jul 29, 2026 | — |
| 425 | Filing | Jul 28, 2026 | — |
| 425 | Filing | Jul 28, 2026 | — |
| 425 | Filing | Jul 20, 2026 | — |
| 425 | Filing | Jun 8, 2026 | — |
| SD | Specialized disclosure (conflict minerals) | May 29, 2026 | — |
| NT 10-Q | Filing | Aug 12, 2025 | Aug 11, 2025 |
| SD | Specialized disclosure (conflict minerals) | Jun 2, 2025 | — |
| EFFECT | Filing | Jun 27, 2024 | — |
| CORRESP | Letter to the SEC | Jun 25, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 25, 2024 | — |
| SD | Specialized disclosure (conflict minerals) | May 29, 2024 | — |
| DEFC14A | Filing | May 21, 2024 | — |
| PRER14A | Filing | May 20, 2024 | — |
| UPLOAD | Letter from the SEC | May 17, 2024 | — |
| PREC14A | Filing | May 10, 2024 | — |
| EFFECT | Filing | Feb 7, 2024 | — |
| EFFECT | Filing | Feb 7, 2024 | — |
| CORRESP | Letter to the SEC | Feb 5, 2024 | — |
| CORRESP | Letter to the SEC | Feb 5, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 1, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 1, 2024 | — |
| 425 | Filing | Dec 29, 2023 | — |
| 425 | Filing | Dec 26, 2023 | — |
| 425 | Filing | Dec 19, 2023 | — |
| 425 | Filing | Dec 4, 2023 | — |
| EFFECT | Filing | Dec 1, 2023 | — |
| CORRESP | Letter to the SEC | Dec 1, 2023 | — |
| 425 | Filing | Nov 29, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 27, 2023 | — |
| 425 | Filing | Nov 21, 2023 | — |
| CORRESP | Letter to the SEC | Nov 13, 2023 | — |
| 425 | Filing | Nov 8, 2023 | — |
| 425 | Filing | Oct 4, 2023 | — |
| 425 | Filing | Oct 4, 2023 | — |
| 425 | Filing | Oct 4, 2023 | — |
| 425 | Filing | Oct 4, 2023 | — |
| 425 | Filing | Oct 4, 2023 | — |
| 425 | Filing | Oct 4, 2023 | — |
| SD | Specialized disclosure (conflict minerals) | May 26, 2023 | — |
| SD | Specialized disclosure (conflict minerals) | May 31, 2022 | — |
| EFFECT | Filing | May 26, 2022 | — |
| CORRESP | Letter to the SEC | May 25, 2022 | — |
| UPLOAD | Letter from the SEC | May 24, 2022 | — |
| DEFR14A | Filing | Mar 29, 2022 | — |
| DEFR14A | Filing | Mar 28, 2022 | — |
| SD | Specialized disclosure (conflict minerals) | May 27, 2021 | — |
| SD | Specialized disclosure (conflict minerals) | May 28, 2020 | — |
| EFFECT | Filing | Apr 30, 2020 | — |
| POSASR | Filing | Feb 14, 2020 | — |
| SD | Specialized disclosure (conflict minerals) | May 30, 2019 | — |
| SD | Specialized disclosure (conflict minerals) | May 30, 2018 | — |
| SC TO-I/A | Filing | Sep 21, 2017 | — |
| SC TO-I | Schedule to | Aug 23, 2017 | — |
| 15-12B | Deregistration | Aug 17, 2017 | — |
| SC TO-C | Form 8-k | Aug 2, 2017 | — |
| 25 | Form 25 | Aug 2, 2017 | — |
| 8-A12B/A | Filing | Aug 2, 2017 | — |
| SC TO-C | Filing | Jun 29, 2017 | — |
| SD | Specialized disclosure (conflict minerals) | May 31, 2017 | — |
| EFFECT | Filing | May 2, 2017 | — |
| CORRESP | Letter to the SEC | Apr 28, 2017 | — |
| 8-A12B | Form 8-a12b | Nov 22, 2016 | — |
| CT ORDER | Filing | Nov 21, 2016 | — |
Showing 68 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LAB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1162194
- Former names
- FLUIDIGM CORP (until Apr 1, 2022)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.